Although our work is the beneficiary of major clinical support through the U.S. National Institutes of Health (via internal work agreements and external grants), donations are critical to fund other work that is also required to advance oxfendazole’s development for human use. The conduct of additional safety studies in animals is a significant need. Examples of these are:
- Studies of oxfendazole’s potential interaction with other medicines that patients may be taking for other medical conditions
- Four-week toxicology studies in rats
- Four-week toxicology studies in a non-rodent species
- Reproductive toxicology studies in rat (FEED study: Fertility and Early Embryonic Development study)
Some of these studies must be conducted before we can advance to Phase III development, the step following the one in which we are presently engaged, Phase II. The cost of the first study listed above is in the range of tens of thousands of dollars, whereas the cost of studies 2 through 4 are in the range of $200-400K each.
Please consider supporting our work to advance a better medicine for the treatment of several Neglected Tropical Diseases. You can easily contribute to this work by using the “Donate” button above
Because we are a 501(c)(3) nonprofit organization, your donation is tax deductible to the fullest extent of the law. We are also a Pennsylvania nonprofit corporation and have registered with the Pennsylvania Department of Charitable Organizations to solicit charitable contributions. Please see our “Nonprofit documentation” tab for these credentials.
If you would like additional information or would like to donate in some other way, please contact us using the “Contact” tab on this web site.